The epithelial sodium channel in inflammation and blood pressure modulation

A major regulator of blood pressure and volume homeostasis in the kidney is the epithelial sodium channel (ENaC). ENaC is composed of alpha(α)/beta(β)/gamma(γ) or delta(δ)/beta(β)/gamma(γ) subunits. The δ subunit is functional in the guinea pig, but not in routinely used experimental rodent models i...

Full description

Bibliographic Details
Main Authors: Taseer Ahmad, Lale A. Ertuglu, Sepiso K. Masenga, Thomas R. Kleyman, Annet Kirabo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1130148/full
_version_ 1797847905985363968
author Taseer Ahmad
Taseer Ahmad
Lale A. Ertuglu
Sepiso K. Masenga
Thomas R. Kleyman
Thomas R. Kleyman
Thomas R. Kleyman
Annet Kirabo
author_facet Taseer Ahmad
Taseer Ahmad
Lale A. Ertuglu
Sepiso K. Masenga
Thomas R. Kleyman
Thomas R. Kleyman
Thomas R. Kleyman
Annet Kirabo
author_sort Taseer Ahmad
collection DOAJ
description A major regulator of blood pressure and volume homeostasis in the kidney is the epithelial sodium channel (ENaC). ENaC is composed of alpha(α)/beta(β)/gamma(γ) or delta(δ)/beta(β)/gamma(γ) subunits. The δ subunit is functional in the guinea pig, but not in routinely used experimental rodent models including rat or mouse, and thus remains the least understood of the four subunits. While the δ subunit is poorly expressed in the human kidney, we recently found that its gene variants are associated with blood pressure and kidney function. The δ subunit is expressed in the human vasculature where it may influence vascular function. Moreover, we recently found that the δ subunit is also expressed human antigen presenting cells (APCs). Our studies indicate that extracellular Na+ enters APCs via ENaC leading to inflammation and salt-induced hypertension. In this review, we highlight recent findings on the role of extra-renal ENaC in inflammation, vascular dysfunction, and blood pressure modulation. Targeting extra-renal ENaC may provide new drug therapies for salt-induced hypertension.
first_indexed 2024-04-09T18:18:51Z
format Article
id doaj.art-67a864c59c304fd79f51acbfc452eeb8
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-09T18:18:51Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-67a864c59c304fd79f51acbfc452eeb82023-04-12T13:02:59ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-04-011010.3389/fcvm.2023.11301481130148The epithelial sodium channel in inflammation and blood pressure modulationTaseer Ahmad0Taseer Ahmad1Lale A. Ertuglu2Sepiso K. Masenga3Thomas R. Kleyman4Thomas R. Kleyman5Thomas R. Kleyman6Annet Kirabo7Department of Pharmacology, College of Pharmacy, University of Sargodha, Sargodha, PakistanDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United StatesDivision of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United StatesDepartment of Physiological Sciences, School of Medicine and Health Sciences, Mulungushi University, Livingstone, ZambiaDepartment of Medicine, University of Pittsburgh, Pittsburgh, PA, United StatesDepartment of Cell Biology, University of Pittsburgh, Pittsburgh, PA, United StatesDepartment of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA, United StatesDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United StatesA major regulator of blood pressure and volume homeostasis in the kidney is the epithelial sodium channel (ENaC). ENaC is composed of alpha(α)/beta(β)/gamma(γ) or delta(δ)/beta(β)/gamma(γ) subunits. The δ subunit is functional in the guinea pig, but not in routinely used experimental rodent models including rat or mouse, and thus remains the least understood of the four subunits. While the δ subunit is poorly expressed in the human kidney, we recently found that its gene variants are associated with blood pressure and kidney function. The δ subunit is expressed in the human vasculature where it may influence vascular function. Moreover, we recently found that the δ subunit is also expressed human antigen presenting cells (APCs). Our studies indicate that extracellular Na+ enters APCs via ENaC leading to inflammation and salt-induced hypertension. In this review, we highlight recent findings on the role of extra-renal ENaC in inflammation, vascular dysfunction, and blood pressure modulation. Targeting extra-renal ENaC may provide new drug therapies for salt-induced hypertension.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1130148/fullepithelial sodium channel (ENaC)δ-ENaCantigen presenting cellsinflammationendothelium dysfunctionblood pressure
spellingShingle Taseer Ahmad
Taseer Ahmad
Lale A. Ertuglu
Sepiso K. Masenga
Thomas R. Kleyman
Thomas R. Kleyman
Thomas R. Kleyman
Annet Kirabo
The epithelial sodium channel in inflammation and blood pressure modulation
Frontiers in Cardiovascular Medicine
epithelial sodium channel (ENaC)
δ-ENaC
antigen presenting cells
inflammation
endothelium dysfunction
blood pressure
title The epithelial sodium channel in inflammation and blood pressure modulation
title_full The epithelial sodium channel in inflammation and blood pressure modulation
title_fullStr The epithelial sodium channel in inflammation and blood pressure modulation
title_full_unstemmed The epithelial sodium channel in inflammation and blood pressure modulation
title_short The epithelial sodium channel in inflammation and blood pressure modulation
title_sort epithelial sodium channel in inflammation and blood pressure modulation
topic epithelial sodium channel (ENaC)
δ-ENaC
antigen presenting cells
inflammation
endothelium dysfunction
blood pressure
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1130148/full
work_keys_str_mv AT taseerahmad theepithelialsodiumchannelininflammationandbloodpressuremodulation
AT taseerahmad theepithelialsodiumchannelininflammationandbloodpressuremodulation
AT laleaertuglu theepithelialsodiumchannelininflammationandbloodpressuremodulation
AT sepisokmasenga theepithelialsodiumchannelininflammationandbloodpressuremodulation
AT thomasrkleyman theepithelialsodiumchannelininflammationandbloodpressuremodulation
AT thomasrkleyman theepithelialsodiumchannelininflammationandbloodpressuremodulation
AT thomasrkleyman theepithelialsodiumchannelininflammationandbloodpressuremodulation
AT annetkirabo theepithelialsodiumchannelininflammationandbloodpressuremodulation
AT taseerahmad epithelialsodiumchannelininflammationandbloodpressuremodulation
AT taseerahmad epithelialsodiumchannelininflammationandbloodpressuremodulation
AT laleaertuglu epithelialsodiumchannelininflammationandbloodpressuremodulation
AT sepisokmasenga epithelialsodiumchannelininflammationandbloodpressuremodulation
AT thomasrkleyman epithelialsodiumchannelininflammationandbloodpressuremodulation
AT thomasrkleyman epithelialsodiumchannelininflammationandbloodpressuremodulation
AT thomasrkleyman epithelialsodiumchannelininflammationandbloodpressuremodulation
AT annetkirabo epithelialsodiumchannelininflammationandbloodpressuremodulation